These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10722622

  • 1. Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.
    Kumar S, Collins W, Egan A, Yadava A, Garraud O, Blackman MJ, Guevara Patino JA, Diggs C, Kaslow DC.
    Infect Immun; 2000 Apr; 68(4):2215-23. PubMed ID: 10722622
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
    Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH.
    Infect Immun; 2001 Mar 15; 69(3):1536-46. PubMed ID: 11179324
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC.
    Mol Med; 1995 Mar 15; 1(3):325-32. PubMed ID: 8529111
    [Abstract] [Full Text] [Related]

  • 5. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
    Chang SP, Case SE, Gosnell WL, Hashimoto A, Kramer KJ, Tam LQ, Hashiro CQ, Nikaido CM, Gibson HL, Lee-Ng CT, Barr PJ, Yokota BT, Hut GS.
    Infect Immun; 1996 Jan 15; 64(1):253-61. PubMed ID: 8557348
    [Abstract] [Full Text] [Related]

  • 6. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA.
    Infect Immun; 2005 Jan 15; 73(1):287-97. PubMed ID: 15618165
    [Abstract] [Full Text] [Related]

  • 7. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF, Blackman MJ, Kaslow DC.
    Infect Immun; 2000 Mar 15; 68(3):1418-27. PubMed ID: 10678955
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P, Ruebush TK, Campbell GH, Richman SJ, Wilkins PP, Broderson JR, Ardeshir F, Gross M, Silverman C, Skinner JC.
    Am J Trop Med Hyg; 1992 Jun 15; 46(6):691-707. PubMed ID: 1621894
    [Abstract] [Full Text] [Related]

  • 9. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
    Infect Immun; 2006 Aug 15; 74(8):4573-80. PubMed ID: 16861644
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
    Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW.
    Infect Immun; 2003 Dec 15; 71(12):6766-74. PubMed ID: 14638762
    [Abstract] [Full Text] [Related]

  • 11. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.
    Hisaeda H, Saul A, Reece JJ, Kennedy MC, Long CA, Miller LH, Stowers AW.
    J Infect Dis; 2002 Mar 01; 185(5):657-64. PubMed ID: 11865423
    [Abstract] [Full Text] [Related]

  • 12. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
    Herrera S, Herrera MA, Certa U, Corredor A, Guerrero R.
    Mem Inst Oswaldo Cruz; 1992 Mar 01; 87 Suppl 3():423-8. PubMed ID: 1343722
    [Abstract] [Full Text] [Related]

  • 13. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B, Hundt E, Knapp B.
    Mem Inst Oswaldo Cruz; 1992 Mar 01; 87 Suppl 3():413-22. PubMed ID: 1343721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.
    Hui GS, Nikaido C, Hashiro C, Kaslow DC, Collins WE.
    Infect Immun; 1996 May 01; 64(5):1502-9. PubMed ID: 8613353
    [Abstract] [Full Text] [Related]

  • 16. Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.
    Lyon JA, Angov E, Fay MP, Sullivan JS, Girourd AS, Robinson SJ, Bergmann-Leitner ES, Duncan EH, Darko CA, Collins WE, Long CA, Barnwell JW.
    PLoS One; 2008 Jul 30; 3(7):e2830. PubMed ID: 18665258
    [Abstract] [Full Text] [Related]

  • 17. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, Soares IS, Costa FT, Rodrigues MM.
    Vaccine; 2010 Apr 01; 28(16):2818-26. PubMed ID: 20170765
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
    Rosa DS, Iwai LK, Tzelepis F, Bargieri DY, Medeiros MA, Soares IS, Sidney J, Sette A, Kalil J, Mello LE, Cunha-Neto E, Rodrigues MM.
    Microbes Infect; 2006 Jul 01; 8(8):2130-7. PubMed ID: 16797207
    [Abstract] [Full Text] [Related]

  • 19. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S, Villinger F, Oakley M, Aguiar JC, Jones TR, Hedstrom RC, Gowda K, Chute J, Stowers A, Kaslow DC, Thomas EK, Tine J, Klinman D, Hoffman SL, Weiss WW.
    Immunol Lett; 2002 Apr 01; 81(1):13-24. PubMed ID: 11841841
    [Abstract] [Full Text] [Related]

  • 20. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection.
    Burghaus PA, Wellde BT, Hall T, Richards RL, Egan AF, Riley EM, Ballou WR, Holder AA.
    Infect Immun; 1996 Sep 01; 64(9):3614-9. PubMed ID: 8751907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.